5-((4-(1,2,4,5-Tetrazin-3-yl)benzyl)carbamoyl)-2-(3,6-bis(dimethylamino)xanthylium-9-yl)benzoate

Catalog No.: 
ACZQKL124
CAS No.: 
1393381-53-7
Molecular Formula: 
C34H29N7O4
Molecular Weight: 
599.65
5-((4-(1,2,4,5-Tetrazin-3-yl)benzyl)carbamoyl)-2-(3,6-bis(dimethylamino)xanthylium-9-yl)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-((4-(1,2,4,5-Tetrazin-3-yl)benzyl)carbamoyl)-2-(3,6-bis(dimethylamino)xanthylium-9-yl)benzoate
IUPAC Name5-((4-(1,2,4,5-tetrazin-3-yl)benzyl)carbamoyl)-2-(6-(dimethylamino)-3-(dimethyliminio)-3H-xanthen-9-yl)benzoate
Molecular FormulaC34H29N7O4
Molecular Weight599.65
SMILESO=C(C1=C(C2=C3C=CC(N(C)C)=CC3=[O+]C4=C2C=CC(N(C)C)=C4)C=CC(C(NCC5=CC=C(C6=NN=CN=N6)C=C5)=O)=C1)[O-]
InChI KeyHOVZORVTGWYPTC-UHFFFAOYSA-N
Synonym5-TAMRA-5-Tetrazine
CAS No.1393381-53-7

Synthetic Route by SureRoute

1. ACZQKL124 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKPTM134 route compound structure diagram
    ACKPTM13491809-66-4 In Stock
  2. Plus
  3. ACLKIV083 route compound structure diagram
    ACLKIV0831416711-59-5 In Stock
  4. Then
  5. ACZQKL124 route product structure diagram
    ACZQKL1241393381-53-7
Inquiry

2. ACZQKL124 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZQKL124 route product structure diagram
    ACZQKL1241393381-53-7
Inquiry

3. ACZQKL124 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZQKL124 route product structure diagram
    ACZQKL1241393381-53-7
Inquiry

Comments (0)